secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biofrontera Inc. (BFRI)
CIK:        0001858685
Form:       8-K
Filed at:   2023-05-12T23:59:59+00:00
Accession:  0001493152-23-016502
Event type: leadership
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biofrontera CEO Monaco resigns; Luebbert takes over; Q1 revenue $8.7M, net loss $7.5M
--------------------------------------------------------------------------------

- CEO Erica Monaco resigning; Executive Chairman Hermann Luebbert to assume CEO role; effective near term.
- Q1 2023 revenue $8.7M, down 11% YoY due to prior-year buy-in; net loss $7.5M vs net income $5.6M.
- Q1 2023 net loss per share $(0.28) vs prior-year EPS $0.32; adjusted EBITDA -$4.0M.
- Cash and cash equivalents $13.5M as of March 31, 2023, down from $17.2M Dec 31, 2022.
- Affirms full-year 2023 revenue growth at least 25% vs 2022; expects cash flow positive within two years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858685/000149315223016502/0001493152-23-016502-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858685/000149315223016502/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-016502

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer